JAMES C YAO to Recombinant Fusion Proteins
This is a "connection" page, showing publications JAMES C YAO has written about Recombinant Fusion Proteins.
Connection Strength
0.438
-
A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. Pancreas. 2019 03; 48(3):381-386.
Score: 0.438
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.